EMD-28540

Single-particle
3.7 Å
EMD-28540
3D View Gallery
Deposition: 08/10/2022
Map released: 19/04/2023
Last modified: 19/06/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-28540
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 8eqn summary report (pdf.gz) Map and 8eqn FULL report (pdf.gz)
EMICSS annotations (xml)

BG505 UFO-E2p-L4P nanoparticle reconstructed by focused refinement with a mask around the nanoparticle core

EMD-28540

Single-particle
3.7 Å
EMD-28540
3D View Gallery
Deposition: 08/10/2022
Map released: 19/04/2023
Last modified: 19/06/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Human immunodeficiency virus 1
Sample: BG505 UFO-E2p-L4P nanoparticle reconstructed by focused refinement with a mask around the nanoparticle core
Fitted models: 8eqn

Deposition Authors: Antanasijevic A, Zhang YN , Zhu J , Ward AB
Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimmers as HIV-1 vaccine candidates.
Zhang YN , Paynter J, Antanasijevic A, Allen JD , Eldad M , Lee YZ , Copps J , Newby ML, He L, Chavez D, Frost P, Goodroe A, Dutton J, Lanford R, Chen C , Wilson IA , Crispin M , Ward AB , Zhu J
(2023) Nat Commun , 14 , 1985 - 1985
PUBMED: 37031217
DOI: doi:10.1038/s41467-023-37742-z
ISSN: 2041-1723